173 related articles for article (PubMed ID: 8425104)
1. Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme.
Delves CJ; Ballantine SP; Tansik RL; Baccanari DP; Stammers DK
Protein Expr Purif; 1993 Feb; 4(1):16-23. PubMed ID: 8425104
[TBL] [Abstract][Full Text] [Related]
2. The hydroxymethyldihydropterin pyrophosphokinase domain of the multifunctional folic acid synthesis Fas protein of Pneumocystis carinii expressed as an independent enzyme in Escherichia coli: refolding and characterization of the recombinant enzyme.
Ballantine SP; Volpe F; Delves CJ
Protein Expr Purif; 1994 Aug; 5(4):371-8. PubMed ID: 7950384
[TBL] [Abstract][Full Text] [Related]
3. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
[TBL] [Abstract][Full Text] [Related]
4. Preliminary crystallographic data for Pneumocystis carinii dihydrofolate reductase.
Stammers DK; Delves C; Ballantine S; Jones EY; Stuart DI; Achari A; Bryant PK; Champness JN
J Mol Biol; 1993 Mar; 230(2):679-80. PubMed ID: 8464076
[TBL] [Abstract][Full Text] [Related]
5. Purification and properties of recombinant Pneumocystis carinii dihydrofolate reductase.
Sirawaraporn W; Edman JC; Santi DV
Protein Expr Purif; 1991; 2(5-6):313-6. PubMed ID: 1821803
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase.
White EL; Ross LJ; Cunningham A; Escuyer V
FEMS Microbiol Lett; 2004 Mar; 232(1):101-5. PubMed ID: 15019741
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase.
Ma L; Kovacs JA
Antimicrob Agents Chemother; 2000 Nov; 44(11):3092-6. PubMed ID: 11036028
[TBL] [Abstract][Full Text] [Related]
8. Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: catalytic properties and interaction with antifolates.
Margosiak SA; Appleman JR; Santi DV; Blakley RL
Arch Biochem Biophys; 1993 Sep; 305(2):499-508. PubMed ID: 8373187
[TBL] [Abstract][Full Text] [Related]
9. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
Cody V; Pace J; Chisum K; Rosowsky A
Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of the dihydrofolate reductase domain of Leishmania major dihydrofolate reductase-thymidylate synthase bifunctional protein.
Yu PL; Zhao J; Yu M; Reid R; Santi DV
Protein Expr Purif; 1996 Aug; 8(1):23-7. PubMed ID: 8812831
[TBL] [Abstract][Full Text] [Related]
11. Soluble expression in Escherichia coli, one-step purification, and characterization of Chinese hamster dihydrofolate reductase.
Fan YX; Wang B; Jing GZ
Protein Expr Purif; 1997 Mar; 9(2):246-52. PubMed ID: 9056490
[TBL] [Abstract][Full Text] [Related]
12. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF
Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348
[TBL] [Abstract][Full Text] [Related]
14. 2,4-Diaminothieno[2,3-d]pyrimidine lipophilic antifolates as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Rosowsky A; Papoulis AT; Queener SF
J Med Chem; 1997 Oct; 40(22):3694-9. PubMed ID: 9357537
[TBL] [Abstract][Full Text] [Related]
15. Non specific PCR products using rat-derived Pneumocystis carinii dihydrofolate reductase gene-specific primers in DNA amplification of human respiratory samples.
Ortona E; Margutti P; De Luca A; Peters SE; Wakefield AE; Tamburrini E; Mencarini P; Visconti E; Siracusano A
Mol Cell Probes; 1996 Jun; 10(3):187-90. PubMed ID: 8799372
[TBL] [Abstract][Full Text] [Related]
16. Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus.
Cinquina CC; Grogan E; Sun R; Lin SF; Beardsley GP; Miller G
Virology; 2000 Mar; 268(1):201-17. PubMed ID: 10683342
[TBL] [Abstract][Full Text] [Related]
17. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene.
Edman JC; Edman U; Cao M; Lundgren B; Kovacs JA; Santi DV
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8625-9. PubMed ID: 2682653
[TBL] [Abstract][Full Text] [Related]
18. Specificity in structure-based drug design: identification of a novel, selective inhibitor of Pneumocystis carinii dihydrofolate reductase.
Gschwend DA; Sirawaraporn W; Santi DV; Kuntz ID
Proteins; 1997 Sep; 29(1):59-67. PubMed ID: 9294866
[TBL] [Abstract][Full Text] [Related]
19. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
[TBL] [Abstract][Full Text] [Related]
20. Structure and hydride transfer mechanism of a moderate thermophilic dihydrofolate reductase from Bacillus stearothermophilus and comparison to its mesophilic and hyperthermophilic homologues.
Kim HS; Damo SM; Lee SY; Wemmer D; Klinman JP
Biochemistry; 2005 Aug; 44(34):11428-39. PubMed ID: 16114879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
